Rosemary Dray-Spira

EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France, France

Disclosure information not submitted.

Presentation(s):

• Association between macrolide exposure in early pregnancy and major congenital malformations: a large French population-based study during 2010-20 period

  Monday, August 26, 2024
  2:00 PM – 2:15 PM CEST

• Influence of mRNA Covid-19 Vaccine Dosing Interval on the Risk of Myocarditis

  Monday, August 26, 2024
  1:45 PM – 2:00 PM CEST

• Adverse pregnancy outcomes associated with in utero exposure to multiple sclerosis disease-modifying therapies in France: a nationwide cohort study

  Tuesday, August 27, 2024
  1:30 PM – 1:45 PM CEST

• Evolution of Contraceptive Use in France From 2012 To 2022

  Wednesday, August 28, 2024
  8:45 AM – 8:50 AM CEST

• Prescription medication use during pregnancy in France between 2010 and 2022: a nationwide study

  Wednesday, August 28, 2024
  9:45 AM – 10:00 AM CEST